Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00701376 · ClinicalTrials.gov registry record · NA
Hepatic Effects of Gastric Bypass Surgery
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT00701376 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 106 participants.
The verdict
NCT00701376, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
Liver disease in the morbidly obese is thought to occur due to the long-term presence of fat deposits in the liver, resulting in inflammation and scarring of the liver over time, which reduces liver function. However, many of these patients are unaware that their liver is damaged. There is currently no consensus regarding what the long-term effects of gastric bypass surgery are on pre-existing liver disease in morbidly obese patients. This study will determine the long-term effects on the liver after this type of surgical procedure.
Interventions
- OTHER liver biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2008-06 |
| Est. Completion | 2014-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00701376
The ClinicalTrials.gov registry entry for NCT00701376 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which liver biopsy is the first listed.
NCT00701376 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00701376 about?
NCT00701376 is a clinical study titled "Hepatic Effects of Gastric Bypass Surgery". Liver disease in the morbidly obese is thought to occur due to the long-term presence of fat deposits in the liver, resulting in inflammation and scarring of the liver over time, which reduces liver function. However, many of these patients are unaware that their liver is damaged. There is currently...
What is the current status of trial NCT00701376?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2008-06. Estimated completion is 2014-09.
What interventions are being tested in trial NCT00701376?
The interventions under investigation include: liver biopsy (OTHER).
Who is sponsoring clinical trial NCT00701376?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.